View Filing Data

DOCUMENT AND ENTITY INFORMATION	3 Months Ended
DOCUMENT AND ENTITY INFORMATION	Jun. 27, 2015 shares
Document And Entity Information [Abstract]
Entity Registrant Name	HAEMONETICS CORP
Entity Central Index Key	0000313143
Current Fiscal Year End Date	--04-02
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 27, 2015
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding	50,886,489

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Income Statement [Abstract]
Net revenues	$ 213,413	$ 224,488
Cost of goods sold	110,874	118,210
Gross profit	102,539	106,278
Operating expenses:
Research and development	11,321	15,382
Selling, general and administrative	87,612	92,562
Total operating expenses	98,933	107,944
Operating income (loss)	3,606	(1,666)
Interest and other expense, net	(2,009)	(2,543)
Income (loss) before provision for (benefit from) income taxes	1,597	(4,209)
Provision for (benefit from) income taxes	1,864	(560)
Net loss	$ (267)	$ (3,649)
Net income (loss) per share - basic (in dollars per share)	$ (0.01)	$ (0.07)
Net income (loss) per share - diluted (in dollars per share)	$ (0.01)	$ (0.07)
Weighted average shares outstanding
Basic (in shares)	51,360	51,741
Diluted (in shares)	51,360	51,741
Comprehensive loss	$ (2,627)	$ (4,495)

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 27, 2015	Mar. 28, 2015
Current assets:
Cash and cash equivalents	$ 112,204	$ 160,662
Accounts receivable, less allowance of $1,805 at June 27, 2015 and $1,749 at March 28, 2015	139,103	145,827
Inventories, net	211,131	211,077
Deferred tax asset, net	12,680	12,608
Prepaid expenses and other current assets	33,243	40,103
Total current assets	508,361	570,277
Net property, plant and equipment	328,882	321,948
Intangible assets, less accumulated amortization of $141,945 at June 27, 2015 and $133,175 at March 28, 2015	241,873	244,588
Goodwill	334,187	334,310
Deferred tax asset, long term	3,080	3,023
Other long-term assets	11,028	11,271
Total assets	1,427,411	1,485,417
Current liabilities:
Notes payable and current maturities of long-term debt	32,396	21,522
Accounts payable	42,155	48,425
Accrued payroll and related costs	40,092	51,115
Accrued taxes	2,780	3,819
Other liabilities	52,342	64,211
Total current liabilities	169,765	189,092
Long-term debt, net of current maturities	399,453	406,369
Long-term deferred tax liability	34,354	32,097
Other long-term liabilities	32,192	31,737
Stockholders’ equity:
Common stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 50,886,489 shares at June 27, 2015 and 51,670,969 shares at March 28, 2015	509	517
Additional paid-in capital	427,878	426,964
Retained earnings	387,344	420,365
Accumulated other comprehensive loss	(24,084)	(21,724)
Total stockholders’ equity	791,647	826,122
Total liabilities and stockholders’ equity	$ 1,427,411	$ 1,485,417

CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Thousands	Jun. 27, 2015	Mar. 28, 2015
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 1,805	$ 1,749
Intangible assets, amortization	$ 141,945	$ 133,175
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	50,886,489	51,670,969
Common stock, shares outstanding (in shares)	50,886,489	51,670,969

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Cash Flows from Operating Activities:
Net loss	$ (267)	$ (3,649)
Non-cash items:
Depreciation and amortization	22,255	20,511
Amortization of financing costs	222	347
Stock compensation expense	3,164	3,489
(Gain)/loss on sale of property, plant and equipment	(25)	414
Unrealized (loss)/gain from hedging activities	(186)	104
Change in fair value of contingent consideration	83	224
Asset write-down	0	261
Change in operating assets and liabilities:
Change in accounts receivable, net	6,574	7,918
Change in inventories	(718)	(9,569)
Change in prepaid income taxes	(369)	(313)
Change in other assets and other liabilities	3,699	(589)
Tax benefit of exercise of stock options	0	285
Change in accounts payable and accrued expenses	(25,182)	(5,695)
Net cash provided by operating activities	9,250	13,738
Cash Flows from Investing Activities:
Capital expenditures on property, plant and equipment	(24,246)	(37,085)
Proceeds from sale of property, plant and equipment	116	64
Other acquisitions and investments	3,000	0
Net cash used in investing activities	(27,130)	(37,021)
Cash Flows from Financing Activities:
Payments on long-term real estate mortgage	(276)	(254)
Net increase in short-term loans	4,380	1,687
Repayment of term loan borrowings	0	(8,531)
Proceeds from employee stock purchase plan	2,263	2,530
Proceeds from exercise of stock options	2,893	2,223
Share repurchases	(39,032)	(26,466)
Net cash used in financing activities	(29,772)	(28,811)
Effect of exchange rates on cash and cash equivalents	(806)	(432)
Net Change in Cash and Cash Equivalents	(48,458)	(52,526)
Cash and Cash Equivalents at Beginning of Period	160,662	192,469
Cash and Cash Equivalents at End of Period	112,204	139,943
Supplemental Disclosures of Cash Flow Information:
Interest paid	2,068	2,011
Income taxes paid	1,625	2,097
Transfers from inventory to fixed assets for placement of Haemonetics equipment	$ 2,925	$ 2,443

BASIS OF PRESENTATION	3 Months Ended
BASIS OF PRESENTATION	Jun. 27, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION Our accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of our management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. All intercompany transactions have been eliminated. Operating results for the three months ended are not necessarily indicative of the results that may be expected for the full fiscal year ending April 2, 2016, or any other interim period. Operating results for the three months ended June 27, 2015 include the correction of an understatement of the provision for income taxes in fiscal 2015, which was determined to be immaterial to all periods impacted. Absent this correction, the provision for income taxes in the three months ended June 27, 2015 would have been $1.0 million lower than the amount included in the accompanying Consolidated Statements of Loss and Comprehensive Loss. This understatement was due to an error in the computation of the provision for income taxes due to a recent change in the capital gains tax rate in Puerto Rico related to certain deferred tax liabilities. These unaudited consolidated financial statements should be read in conjunction with our audited consolidated financial statements and footnotes included in our annual report on Form 10-K for the fiscal year ended March 28, 2015. We consider events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. We had no significant subsequent events. Our fiscal year ends on the Saturday closest to the last day of March. Fiscal year 2016 includes 53 weeks with each of the first three quarters having 13 weeks and the fourth quarter having 14 weeks. Fiscal year 2015 included 52 weeks with each quarter having 13 weeks.

RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
RECENT ACCOUNTING PRONOUNCEMENTS	Jun. 27, 2015
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	RECENT ACCOUNTING PRONOUNCEMENTS Standards Implemented In April 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. ASU No. 2014-08 limits the requirement to report discontinued operations to disposals of components of an entity that represent strategic shifts that have (or will have) a major effect on an entity’s operations and financial results. The amendments also require expanded disclosures concerning discontinued operations and disclosures of certain financial results attributable to a disposal of a significant component of an entity that does not qualify for discontinued operations reporting. The amendments in ASU No. 2014-08 are effective prospectively for reporting periods beginning on or after December 15, 2014, with early adoption permitted. Management does not believe that the adoption of ASU No. 2014-08 will have a material effect on our Financial Statements. We adopted ASU No. 2014-08 beginning in the first quarter of fiscal 2016. The adoption of ASU No. 2014-08 did not impact our financial position or results of operations. Standards to be Implemented In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU No. 2014-09 stipulates that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, an entity should apply the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the entity satisfies a performance obligation. ASU No. 2014-09 will be effective for annual reporting periods beginning after December 15, 2016, including interim periods within those reporting periods, with early adoption not permitted. On July 9, 2015, the FASB affirmed its proposal to defer the effective date by one year to December 15, 2017 for interim and annual reporting periods beginning after that date and permitted early adoption of the standard, but not before the original effective date of December 15, 2016. The FASB expects to issue its final ASU formally amending the effective date by the end of the third quarter of 2015. The impact of adopting ASU No. 2014-09 on our financial position and results of operations is being assessed by management. In June 2014, the FASB issued ASU No. 2014-12, Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. ASU No. 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in ASC 718, Compensation—Stock Compensation, as it relates to such awards. ASU No. 2014-12 is effective in our first quarter of fiscal 2017 with early adoption permitted using either of two methods: (i) prospective to all awards granted or modified after the effective date; or (ii) retrospective to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter, with the cumulative effect of applying ASU No. 2014-12 as an adjustment to the opening retained earnings balance as of the beginning of the earliest annual period presented in the financial statements. Management does not believe that the adoption of ASU No. 2014-12 will have a material effect on our financial position or results of operations. In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. ASU No. 2014-15 defines management's responsibility to assess an entity's ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. This guidance will be effective for all entities in the first annual period ending after December 15, 2016; however, early adoption is permitted. Management does not believe that the adoption of ASU No. 2014-15 will have a material effect on our financial position or results of operations. In January 2015, the FASB issued ASU No. 2015-01, Income Statement-Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items. ASU No. 2015-01 eliminates from GAAP the concept of extraordinary items. An entity will no longer be required to (1) segregate an extraordinary item from the results of ordinary operations; (2) separately present an extraordinary item on its income statement, net of tax, after income from continuing operations; and (3) disclose income taxes and earnings-per-share data applicable to an extraordinary item. ASU No. 2015-01 will be effective for fiscal years beginning after December 15, 2015. An entity may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. Management does not believe that the adoption of ASU No. 2015-01 will have a material effect on our financial position or results of operations. In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis. ASU No. 2015-02 amended the process that a reporting entity must perform to determine whether it should consolidate certain types of legal entities. ASU No. 2015-02 is effective for annual periods ending after December 15, 2015, and for annual periods and interim periods thereafter with early adoption permitted. Management does not believe that the adoption of ASU No. 2015-02 will have a material effect on our financial position or results of operations. In April 2015, the FASB issued ASU No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. ASU No. 2015-03 requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. ASU No. 2015-03 is effective for annual periods beginning after December 15, 2015, and interim periods within those annual periods. Management does not believe that the adoption of ASU No. 2015-03 will have a material effect on our financial position or results of operations. In April 2015, the FASB issued ASU No. 2015-04, Compensation—Retirement Benefits (Topic 715): Practical Expedient for the Measurement Date of an Employer’s Defined Benefit Obligation and Plan Assets. ASU No. 2015-04 provides a practical expedient, for an entity with a fiscal year-end that does not coincide with a month-end, that permits the entity to measure defined benefit plan assets and obligations using the month-end that is closest to the entity's fiscal year-end and apply that practical expedient consistently from year to year. ASU No. 2015-04 is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. Early application is permitted. Management does not believe that the adoption of ASU No. 2015-04 will have a material effect on our financial position or results of operations. In April 2015, the FASB issued ASU No. 2015-05, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement. ASU No. 2015-05 will help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement. ASU No. 2015-05 is effective for interim and annual periods beginning after December 15, 2015 with early adoption permitted. Management does not believe that the adoption of ASU No. 2015-05 will have a material effect on our financial position or results of operations.

- Definition

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6510796

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305

+ Details

EARNINGS PER SHARE ("EPS")

3 Months Ended

Jun. 27, 2015

Earnings Per Share [Abstract]

EARNINGS PER SHARE (EPS)

EARNINGS PER SHARE (“EPS”)

The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations.



	Three Months Ended
(In thousands, except per share amounts)	June 27, 2015			June 28, 2014
Basic EPS
Net loss	$	(267	)	$	(3,649	)
Weighted average shares	51,360			51,741
Basic loss per share	$	(0.01	)	$	(0.07	)
Diluted EPS
Net loss	$	(267	)	$	(3,649	)
Basic weighted average shares	51,360			51,741
Net effect of common stock equivalents	—			—
Diluted weighted average shares	51,360			51,741
Diluted loss per share	$	(0.01	)	$	(0.07	)

Basic earnings per share is calculated using our weighted-average outstanding common shares. Diluted earnings per share is calculated using our weighted-average outstanding common shares including the dilutive effect of stock awards as determined under the treasury stock method. For the three months ended June 27, 2015 and June 28, 2014, we recognized a net loss; therefore we excluded the impact of outstanding stock awards from the diluted loss per share calculation as their inclusion would have an anti-dilutive effect.

STOCK-BASED COMPENSATION

3 Months Ended

Jun. 27, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK-BASED COMPENSATION

Total stock-based compensation expense of $3.2 million and $3.5 million was recognized for the three months ended June 27, 2015 and June 28, 2014, respectively. There was no income tax benefit recognized for the three months ended June 27, 2015 and the related income tax benefit recognized was $1.1 million for the three months ended June 28, 2014.

The weighted average fair value for our options granted was $9.98 and $7.49 per share for the three months ended June 27, 2015 and June 28, 2014, respectively. The assumptions utilized for estimating the fair value of option grants during the periods presented are as follows:



	Three Months Ended
	June 27, 2015		June 28, 2014
Stock Options Black-Scholes assumptions (weighted average):
Volatility	22.38	%	22.62	%
Expected life (years)	4.9		4.9
Risk-free interest rate	1.75	%	1.64	%
Dividend yield	—	%	—	%

As of June 27, 2015, there was $21.9 million of total unrecognized compensation cost related to non-vested equity based compensation, including stock options, restricted stock units, market stock units and performance share units. This cost is expected to be recognized over a weighted average period of 2.13 years.

During the three months ended June 27, 2015 and June 28, 2014, there were 73,360 and 96,853 shares, respectively, purchased under the Employee Stock Purchase Plan at an average price of $30.84 and $25.85 per share, respectively.

PRODUCT WARRANTIES

3 Months Ended

Jun. 27, 2015

Product Warranties Disclosures [Abstract]

PRODUCT WARRANTIES

We generally provide warranty on parts and labor for one year after the sale and installation of each device. We also warrant our disposables products through their use or expiration. We estimate our potential warranty expense based on our historical warranty experience and periodically assess the adequacy of our warranty accrual, making adjustments as necessary.



	Three Months Ended
(In thousands)	June 27, 2015			June 28, 2014
Warranty accrual as of the beginning of the period	$	531		$	590
Warranty provision	172			75
Warranty spending	(266		)	(154		)
Warranty accrual as of the end of the period	$	437		$	511

INVENTORIES

3 Months Ended

Jun. 27, 2015

Inventory Disclosure [Abstract]

INVENTORIES

Inventories are stated at the lower of cost or market and include the cost of material, labor and manufacturing overhead. Cost is determined using the first-in, first-out method.



(In thousands)	June 27, 2015		March 28, 2015
Raw materials	$	69,586	$	71,794
Work-in-process	10,702		12,462
Finished goods	130,843		126,821
	$	211,131	$	211,077

DERIVATIVES AND FAIR VALUE MEASUREMENTS

3 Months Ended

Jun. 27, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES AND FAIR VALUE MEASUREMENTS

We manufacture, market and sell our products globally. For the three months ended June 27, 2015, approximately 43.4% of our sales were generated outside the U.S. in local currencies. We also incur certain manufacturing, marketing and selling costs in international markets in local currency.

Accordingly, our earnings and cash flows are exposed to market risk from changes in foreign currency exchange rates relative to the U.S. Dollar, our reporting currency. We have a program in place that is designed to mitigate our exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the impact on our financial results from changes in foreign exchange rates. We utilize foreign currency forward contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily the Japanese Yen and the Euro, and to a lesser extent the Swiss Franc, Australian Dollar, British Pound Sterling, Canadian Dollar and the Mexican Peso. This does not eliminate the impact of the volatility of foreign exchange rates, but because we generally enter into forward contracts one year out, rates are fixed for a one-year period, thereby facilitating financial planning and resource allocation.

Designated Foreign Currency Hedge Contracts

All of our designated foreign currency hedge contracts as of June 27, 2015 and March 28, 2015 were cash flow hedges under ASC Topic 815, Derivatives and Hedging. We record the effective portion of any change in the fair value of designated foreign currency hedge contracts in Other Comprehensive Income until the related third-party transaction occurs. Once the related third-party transaction occurs, we reclassify the effective portion of any related gain or loss on the designated foreign currency hedge contracts to earnings. In the event the hedged forecasted transaction does not occur, or it becomes probable that it will not occur, we would reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. We had designated foreign currency hedge contracts outstanding in the contract amount of $132.1 million as of June 27, 2015 and $145.8 million as of March 28, 2015.

During the three months ended June 27, 2015, we recognized net gains of $4.0 million in earnings from our cash flow hedges, compared to recognized net gains of $0.8 million during the three months ended June 28, 2014. For the three months ended June 27, 2015, a $1.2 million gain, net of tax, was recorded in Accumulated Other Comprehensive Income to recognize the effective portion of the fair value of any designated foreign currency hedge contracts that are, or previously were, designated as foreign currency cash flow hedges, as compared to a loss of $0.1 million, net of tax, for the three months ended June 28, 2014. At June 27, 2015, gains of $1.2 million, net of tax, will be reclassified to earnings within the next twelve months. All currency cash flow hedges outstanding as of June 27, 2015 mature within twelve months.

Non-Designated Foreign Currency Contracts

We manage our exposure to changes in foreign currency on a consolidated basis to take advantage of offsetting transactions and balances. We use foreign currency forward contracts as a part of our strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC Topic 815. These forward contracts are marked-to-market with changes in fair value recorded to earnings. We had non-designated foreign currency hedge contracts under ASC Topic 815 outstanding in the contract amount of $38.0 million as of June 27, 2015 and $45.8 million as of March 28, 2015.

Interest Rate Swaps

On August 1, 2012, we entered into a credit agreement, as amended June 30, 2014, which provided for a term loan (“Credit Agreement”). Under the terms of this Credit Agreement, we may borrow at a spread to an index, including the LIBOR index of 1-month, 3-months, 6-months, etc. From the date of the Credit Agreement, we have chosen to borrow against the 1-month USD-LIBOR-BBA rounded up, if necessary, to the nearest 1/16th of 1% (“Adjusted LIBOR”). The terms of the Credit Agreement allows us to borrow in multiple tranches. As of June 27, 2015, we have four tranches outstanding.

Accordingly, our earnings and cash flows are exposed to interest rate risk from changes in Adjusted LIBOR. Part of our interest rate risk management strategy includes the use of interest rate swaps to mitigate our exposure to changes in variable interest rates. Our objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations. We formally document our hedge relationships (including identifying the hedged instrument and hedged item) at hedge inception to ensure that our interest rate swaps qualify for hedge accounting. On a quarterly basis, we assess whether the interest rate swaps are highly effective in offsetting changes in the cash flow of the hedged item. We do not hold or issue interest rate swaps for trading purposes. We manage the credit risk of the counterparties by dealing only with institutions that we consider financially sound and consider the risk of non-performance to be remote.

On December 21, 2012, we entered into two interest rate swap agreements (the "Swaps"), whereby we receive Adjusted LIBOR and pay an average fixed rate of 0.68% on a total notional amount of $250.0 million of debt. The Swaps mature on August 1, 2017. We designated the Swaps as cash flow hedges of variable interest rate risk associated with $250.0 million of indebtedness. For the three months ended June 27, 2015 and June 28, 2014, a nominal gain and a gain of $0.6 million, respectively, net of tax, were recorded in Accumulated Other Comprehensive Income to recognize the effective portion of the fair value of interest rate swaps that qualify as cash flow hedges.

Fair Value of Derivative Instruments

The following table presents the effect of our derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC Topic 815 in our consolidated statements of income and comprehensive income for the three months ended June 27, 2015:



Derivative Instruments	Amount of Gain/(Loss) Recognized in AOCI		Amount of Gain/(Loss) Reclassified from AOCI into Retained Earnings		Location in Consolidated Statements of Income and Comprehensive Income	Amount of Gain/(Loss) Excluded from Effectiveness Testing *		Location in Consolidated Statements of Income and Comprehensive Income
(In thousands)
Designated foreign currency hedge contracts, net of tax	$	1,183	$	3,993	Net revenues, COGS, and SG&A	$	16	Interest and other expense, net
Non-designated foreign currency hedge contracts	—		—			621		Interest and other expense, net
Designated interest rate swaps, net of tax	$	7	$	—	Interest and other expense, net	$	—

* We exclude the difference between the spot rate and hedge forward rate from our effectiveness testing.

We did not have fair value hedges or net investment hedges outstanding as of June 27, 2015 or March 28, 2015.

As of June 27, 2015, the amount recognized as a deferred tax liability for designated foreign currency hedges was $0.7 million and the amount recognized as a deferred tax asset for interest rate swap hedges was $0.1 million.

ASC Topic 815 requires all derivative instruments to be recognized at their fair value as either assets or liabilities on the balance sheet. We determine the fair value of our derivative instruments using the framework prescribed by ASC Topic 820, Fair Value Measurements and Disclosures, by considering the estimated amount we would receive or pay to sell or transfer these instruments at the reporting date and by taking into account current interest rates, currency exchange rates, current interest rate curves, interest rate volatilities, the creditworthiness of the counterparty for assets and our creditworthiness for liabilities. In certain instances, we may utilize financial models to measure fair value. Generally, we use inputs that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. As of June 27, 2015, we have classified our derivative assets and liabilities within Level 2 of the fair value hierarchy prescribed by ASC 815, as discussed below, because these observable inputs are available for substantially the full term of our derivative instruments.

The following tables present the fair value of our derivative instruments as they appear in our consolidated balance sheets as of June 27, 2015 and March 28, 2015:



(In thousands)	Location in Balance Sheet	June 27, 2015		March 28, 2015
Derivative Assets:
Designated foreign currency hedge contracts	Other current assets	$	5,647	$	9,740
		$	5,647	$	9,740
Derivative Liabilities:
Designated foreign currency hedge contracts	Other current liabilities	$	1,334	$	2,499
Designated interest rate swaps	Other current liabilities	148		159
		$	1,482	$	2,658

Other Fair Value Measurements

ASC Topic 820, Fair Value Measurements and Disclosures, defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. ASC Topic 820 does not require any new fair value measurements; rather, it applies to other accounting pronouncements that require or permit fair value measurements. In accordance with ASC Topic 820, for the three months ended June 27, 2015, we applied the requirements under ASC Topic 820 to our non-financial assets and non-financial liabilities. As we did not have an impairment of any non-financial assets or non-financial liabilities, there was no disclosure required relating to our non-financial assets or non-financial liabilities.

On a recurring basis, we measure certain financial assets and financial liabilities at fair value, including our money market funds, foreign currency hedge contracts, and contingent consideration. ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. We base fair value upon quoted market prices, where available. Where quoted market prices or other observable inputs are not available, we apply valuation techniques to estimate fair value.

ASC Topic 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The categorization of assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:


•	Level 1 — Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.


•	Level 2 — Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.


•	Level 3 — Inputs to the valuation methodology are unobservable inputs based on management’s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.

Our money market funds carried at fair value are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.

Fair Value Measured on a Recurring Basis

Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of June 27, 2015.



(In thousands)	Quoted Market Prices for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets
Money market funds	$	71,099	$	—	$	—	$	71,099
Designated foreign currency hedge contracts	—		5,647		—		5,647
	$	71,099	$	5,647	$	—	$	76,746
Liabilities
Designated foreign currency hedge contracts	$	—	$	1,334	$	—	$	1,334
Designated interest rate swap	—		148		—		148
Contingent consideration	—		—		4,810		4,810
	$	—	$	1,482	$	4,810	$	6,292

For the three months ended June 27, 2015, non-designated foreign currency hedge contracts were not significant and are not disclosed separately in the above table.

Contingent Consideration

Contingent consideration liabilities are measured at fair value using projected revenues, discount rates, probabilities of payment and projected payment dates. This Level 3 fair value measurement was performed using a probability-weighted discounted cash flow over a ten year period. Increases or decreases in the fair value of our contingent consideration liability can result from changes in discount periods and rates, as well as changes in the timing and amount of revenue estimates or likelihood of earning revenue. Projected revenues are based on our most recent internal operational budgets.

The table below provides a reconciliation of the beginning and ending Level 3 liabilities for the quarter ended June 27, 2015.



(In thousands)	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Contingent consideration as of March 28, 2015	$	4,727
Fair value adjustment	83
Ending balance	$	4,810

The fair value adjustment to contingent consideration was a result of updated assumptions pertaining to timing and unit volumes.

Other Fair Value Disclosures

The Term Loan (which is carried at amortized cost), accounts receivable and accounts payable approximate fair value.

INCOME TAXES	3 Months Ended
INCOME TAXES	Jun. 27, 2015
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES We conduct business globally, and as a result, report our results of operations in a number of foreign jurisdictions in addition to the United States. The reported income tax rate for the three months ended June 27, 2015 was 116.7%, as compared to a reported income tax rate of 13.3% for the three months ended June 28, 2014. During the three months ended June 27, 2015, we recorded pre-tax losses in Scotland, Italy and Malaysia due to restructuring and transformation costs associated with our manufacturing transformation, and we did not record a corresponding tax benefit due to uncertainty around our ability to realize a tax benefit in these jurisdictions. Similarly, during the three months ended June 28, 2014, we recorded pre-tax losses in Scotland associated with restructuring costs, and we did not record a corresponding tax benefit due to uncertainty around our ability to realize a tax benefit in this jurisdiction. We also recorded tax expense of $1.0 million for the three months ended June 27, 2015 to increase the deferred tax liability related to amortizable goodwill as a result of the statutory capital gains tax rate in Puerto Rico increasing from 15% to 20%. We are in a three year cumulative loss position in the U.S. and accordingly have established a valuation allowance against U.S. deferred tax assets.

DEBT

3 Months Ended

Jun. 27, 2015

Debt Disclosure [Abstract]

DEBT

In connection with the acquisition of the whole blood business, we entered into a credit agreement ("Credit Agreement") with certain lenders (together, “Lenders”) which provided for a $475.0 million Term Loan and a $50.0 million revolving loan (the “Revolving Credit Facility”), and together with the Term Loan, (the “Credit Facilities”). The Credit Facilities had a term of five years and mature on August 1, 2017. Interest was based on the Adjusted LIBOR plus a range of 1.125% to 1.500% depending on the achievement of leverage ratios and customary credit terms which included financial and negative covenants.

On June 30, 2014, we modified our existing Credit Facilities by extending the maturity date to July 1, 2019, extending the principal repayments of the Term Loan, and modifying certain restrictive covenants to allow greater operational flexibility and enhanced near term liquidity. In addition, the amended Credit Agreement provides for a $100.0 million revolving credit facility and establishes interest rates in the range of LIBOR plus 1.125% – 1.500%, depending on certain conditions. At June 27, 2015, $379.4 million was outstanding under the term loan and $50.0 million was outstanding on the Revolving Credit Facility, both with an interest rate of 1.5625%. No additional amounts were borrowed as a result of this modification. The fair value of debt approximates its current value of approximately $429.4 million as of June 27, 2015. We were in compliance with the leverage and interest coverage ratios specified in the Credit Agreement as well as all other bank covenants as of June 27, 2015.

The maturity profile is as follows:



Fiscal year (in thousands)	Term Loan
2016	$	21,342
2017	42,683
2018	45,054
2019	151,763
2020	168,564
	$	429,406

COMMITMENTS AND CONTINGENCIES	3 Months Ended
COMMITMENTS AND CONTINGENCIES	Jun. 27, 2015
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES We are presently engaged in various legal actions, and although the total liability cannot be determined at the present time, based on consultation with counsel, we believe that any such liability will not materially affect our consolidated financial position or our results of operations. Italian Employment Litigation Our Italian manufacturing subsidiary is party to several actions initiated by employees of the facility in Ascoli-Piceno, Italy where we have ceased manufacturing operations. These include actions claiming (i) working conditions and minimum salaries should have been established by either a different classification under their national collective bargaining agreement or a different agreement altogether, (ii) certain solidarity agreements, which are arrangements between the Company, employees and the government to continue full pay and benefits for employees who would otherwise be terminated in times of low demand, are void, and (iii) payment of the extra time used for changing into and out of the working clothes at the beginning and end of each shift. In addition, a union represented in the Ascoli plant has filed an action claiming that the Company discriminated against it in favor of three other represented unions by (i) interfering with an employee referendum, (ii) interfering with an employee petition to recall union representatives from office, and (iii) excluding the union from certain meetings. Finally, we have been added as defendants on claims filed against Pall Corporation prior to our acquisition of the plant in August 2012. These claims relate to agreements to "freeze" benefit allowances for a certain period in exchange for Pall's commitments on hiring and plant investment. As of June 27, 2015, the total amount of damages claimed by the plaintiffs in these matters is approximately $3.7 million. It is not possible at this point in the proceedings to accurately evaluate the likelihood or amount of any potential losses and therefore no amounts have been accrued. We may receive other, similar claims in the future.

SEGMENT INFORMATION	3 Months Ended
SEGMENT INFORMATION	Jun. 27, 2015
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION We manage a global business which designs, manufactures and markets blood management solutions. Our solutions are marketed through operating units organized primarily on geography: North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific and Japan. ASC 280, Segment Reporting, permits the aggregation of segments which are economically similar as well as similar in all of the following areas: (i) the nature of the products and services, (ii) the nature of the production processes, (iii) the type or class of customer for their products and services, (iv) the methods used to distribute their products or provide their services, and (v) the nature of the regulatory environment. Based on the criteria of ASC 280, we have one reportable segment. This conclusion is consistent with how our chief operating decision-maker views the business. Our chief operating decision maker primarily uses consolidated results to make operating and strategic decisions.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

RESTRUCTURING

3 Months Ended

Jun. 27, 2015

Restructuring and Related Activities [Abstract]

RESTRUCTURING

On an ongoing basis, we review the global economy, the healthcare industry and the markets in which we compete to identify opportunities for efficiencies, enhance commercial capabilities, align our resources and offer our customers better solutions. In order to realize these opportunities, we undertake restructuring-type activities to transform our business.

On May 1, 2013, we committed to a plan to pursue identified Value Creation and Capture initiatives ("VCC"). These opportunities include investment in product line extensions and next generation products, enhancement of commercial capabilities and a transformation of our manufacturing network. The transformation of our manufacturing network will take place over three years and includes changes to the current manufacturing footprint and supply chain structure (the "Network Plan"). To implement the Network Plan, we are (i) discontinuing manufacturing activities at our Braintree, Massachusetts, Ascoli-Piceno, Italy and Bothwell, Scotland facilities, (ii) creating a technology center of excellence for product development in Braintree, Massachusetts, (iii) expanding our current facility in Tijuana, Mexico, (iv) engaging Sanmina Corporation as a contract manufacturer to produce certain medical equipment, and (v) building a new manufacturing facility in Penang, Malaysia closer to our customers in Asia. See the Liquidity and Capital Resources discussion of the MD&A for further discussion of the costs of these activities.

We estimate we will incur approximately $45.0 million in restructuring and restructuring related expense in 2016.

The following summarizes the restructuring costs for the three months ended June 27, 2015 and June 28, 2014:



	Three Months Ended June 27, 2015
(In thousands)	Restructuring Accrual Balance at March 28, 2015		Restructuring Costs Incurred		Less Payments			Less Non-Cash Adjustments			Restructuring Accrual Balance at June 27, 2015
Severance and other employee costs	$	16,393	$	6,859	$	(8,155	)	$	—		$	15,097
Other costs	219		2,175		(2,266		)	—			128
Accelerated depreciation	—		421		—			(421		)	—
Asset write-down	—		4		—			(4		)	—
Total	$	16,612	$	9,459	$	(10,421	)	$	(425	)	$	15,225



	Three Months Ended June 28, 2014
(in thousands)	Restructuring Accrual Balance at March 29, 2014		Restructuring Costs Incurred		Less Payments			Less Non-Cash Adjustments			Restructuring Accrual Balance at June 28, 2014
Severance and other employee costs	$	22,908	$	9,542	$	(7,133	)	$	—		$	25,317
Other costs	728		5,167		(5,493		)	—			402
Accelerated depreciation	—		260		—			(260		)	—
Asset write-down	—		96		—			(96		)	—
	$	23,636	$	15,065	$	(12,626	)	$	(356	)	$	25,719

We deployed significant financial resources for these activities. Many of the costs necessary to complete the VCC initiatives, such as severance and other plant closing costs, qualify as restructuring expenses under ASC 420, Exit or Disposal Cost Obligations. We incurred $9.5 million in severance, asset write-downs and other restructuring charges during the three months ended June 27, 2015. In addition, we also incurred $5.4 million of costs that do not constitute restructuring under ASC 420, which we refer to as "Transformation Costs". These costs consist primarily of expenditures directly related to our transformation activities including program management, product line transfer teams and related costs, infrastructure related costs, accelerated depreciation and asset disposals.

The table below presents transformation and restructuring costs recorded in cost of goods sold, research and development, selling, general and administrative expenses and interest and other expense in our Consolidated Statements of Income and Comprehensive Income for the periods presented.



Transformation costs	Three Months Ended
(in thousands)	June 27, 2015		June 28, 2014
Transformation and other costs	$	5,326	$	7,678
Accelerated depreciation	31		250
Total	$	5,357	$	7,928



Restructuring costs	Three Months Ended
(in thousands)	June 27, 2015		June 28, 2014
Severance and other employee costs	$	6,859	$	9,542
Other costs	2,175		5,167
Accelerated depreciation	421		260
Asset disposal	4		96
Total	$	9,459	$	15,065

Total restructuring and transformation	$	14,816	$	22,993

CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS	3 Months Ended
CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS	Jun. 27, 2015
Research and Development [Abstract]
CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS	CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS For costs incurred related to the development of software to be sold, leased or otherwise marketed, we apply the provisions of ASC 985-20, Software - Costs of Software to be Sold, Leased or Marketed, which specifies that costs incurred internally in researching and developing a computer software product should be charged to expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs should be capitalized until the product is available for general release to customers. We capitalized $3.9 million and $1.4 million in software development costs for ongoing initiatives during the three months ended June 27, 2015 and June 28, 2014, respectively. At June 27, 2015 and March 28, 2015, we have a total of $43.6 million and $39.7 million of capitalized software costs, of which $5.9 million and $7.9 million are related to in-process software development initiatives, respectively. During the three months ended June 27, 2015, $5.8 million of capitalized costs were placed into service. The costs capitalized for each project are included in intangible assets in the consolidated financial statements. We review these assets for impairment at least annually.

- Definition

The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.

+ References + Details

ACCUMULATED OTHER COMPREHENSIVE INCOME

3 Months Ended

Jun. 27, 2015

Stockholders' Equity Note [Abstract]

ACCUMULATED OTHER COMPREHENSIVE INCOME

The following is a roll-forward of the components of Accumulated Other Comprehensive Income, net of tax, for the three months ended June 27, 2015:



(In thousands)	Foreign Currency			Defined Benefit Plans			Net Unrealized (Gain)/Loss on Derivatives			Total

Balance as of March 28, 2015	$	(20,512	)	$	(8,923	)	$	7,711		$	(21,724	)
Other comprehensive income (loss)/income before reclassifications	441			2			1,190			1,633
Amounts reclassified from Accumulated Other Comprehensive Income	—			—			(3,993		)	(3,993		)
Net current period other comprehensive (loss)/income	441			2			(2,803		)	(2,360		)
Balance as of June 27, 2015	$	(20,071	)	$	(8,921	)	$	4,908		$	(24,084	)

Details pertaining to the amount reclassified from Accumulated Other Comprehensive Income for the three months ended June 27, 2015 are as follows:



	Amounts Reclassified from Other Comprehensive Income			Affected Line in the Statement of Income
Derivative instruments reclassified to income statement
Realized net gain on derivatives	$	4,152		Revenue, cost of goods sold, income/(expense)
Income tax effect	(159		)	Provision for income taxes
Net of taxes	$	3,993

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

+ Details

EARNINGS PER SHARE ("EPS") (Tables)

3 Months Ended

Jun. 27, 2015

Earnings Per Share [Abstract]

Schedule of Earnings Per Share Reconciliation

The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations.



	Three Months Ended
(In thousands, except per share amounts)	June 27, 2015			June 28, 2014
Basic EPS
Net loss	$	(267	)	$	(3,649	)
Weighted average shares	51,360			51,741
Basic loss per share	$	(0.01	)	$	(0.07	)
Diluted EPS
Net loss	$	(267	)	$	(3,649	)
Basic weighted average shares	51,360			51,741
Net effect of common stock equivalents	—			—
Diluted weighted average shares	51,360			51,741
Diluted loss per share	$	(0.01	)	$	(0.07	)

STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Jun. 27, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Assumptions Utilized for Estimating Fair Value of Option Grants

The assumptions utilized for estimating the fair value of option grants during the periods presented are as follows:



	Three Months Ended
	June 27, 2015		June 28, 2014
Stock Options Black-Scholes assumptions (weighted average):
Volatility	22.38	%	22.62	%
Expected life (years)	4.9		4.9
Risk-free interest rate	1.75	%	1.64	%
Dividend yield	—	%	—	%

PRODUCT WARRANTIES (Tables)

3 Months Ended

Jun. 27, 2015

Product Warranties Disclosures [Abstract]

Schedule of Product Warranty Liability

We estimate our potential warranty expense based on our historical warranty experience and periodically assess the adequacy of our warranty accrual, making adjustments as necessary.



	Three Months Ended
(In thousands)	June 27, 2015			June 28, 2014
Warranty accrual as of the beginning of the period	$	531		$	590
Warranty provision	172			75
Warranty spending	(266		)	(154		)
Warranty accrual as of the end of the period	$	437		$	511

INVENTORIES (Tables)

3 Months Ended

Jun. 27, 2015

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories are stated at the lower of cost or market and include the cost of material, labor and manufacturing overhead. Cost is determined using the first-in, first-out method.



(In thousands)	June 27, 2015		March 28, 2015
Raw materials	$	69,586	$	71,794
Work-in-process	10,702		12,462
Finished goods	130,843		126,821
	$	211,131	$	211,077

DERIVATIVES AND FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Jun. 27, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments



Derivative Instruments	Amount of Gain/(Loss) Recognized in AOCI		Amount of Gain/(Loss) Reclassified from AOCI into Retained Earnings		Location in Consolidated Statements of Income and Comprehensive Income	Amount of Gain/(Loss) Excluded from Effectiveness Testing *		Location in Consolidated Statements of Income and Comprehensive Income
(In thousands)
Designated foreign currency hedge contracts, net of tax	$	1,183	$	3,993	Net revenues, COGS, and SG&A	$	16	Interest and other expense, net
Non-designated foreign currency hedge contracts	—		—			621		Interest and other expense, net
Designated interest rate swaps, net of tax	$	7	$	—	Interest and other expense, net	$	—

* We exclude the difference between the spot rate and hedge forward rate from our effectiveness testing.

Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets

The following tables present the fair value of our derivative instruments as they appear in our consolidated balance sheets as of June 27, 2015 and March 28, 2015:



(In thousands)	Location in Balance Sheet	June 27, 2015		March 28, 2015
Derivative Assets:
Designated foreign currency hedge contracts	Other current assets	$	5,647	$	9,740
		$	5,647	$	9,740
Derivative Liabilities:
Designated foreign currency hedge contracts	Other current liabilities	$	1,334	$	2,499
Designated interest rate swaps	Other current liabilities	148		159
		$	1,482	$	2,658

Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis

Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of June 27, 2015.



(In thousands)	Quoted Market Prices for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets
Money market funds	$	71,099	$	—	$	—	$	71,099
Designated foreign currency hedge contracts	—		5,647		—		5,647
	$	71,099	$	5,647	$	—	$	76,746
Liabilities
Designated foreign currency hedge contracts	$	—	$	1,334	$	—	$	1,334
Designated interest rate swap	—		148		—		148
Contingent consideration	—		—		4,810		4,810
	$	—	$	1,482	$	4,810	$	6,292

Schedule of Fair Value Measurements Using Significant Unobservable Inputs (Level 3)

The table below provides a reconciliation of the beginning and ending Level 3 liabilities for the quarter ended June 27, 2015.



(In thousands)	Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Contingent consideration as of March 28, 2015	$	4,727
Fair value adjustment	83
Ending balance	$	4,810

DEBT (Tables)

3 Months Ended

Jun. 27, 2015

Debt Disclosure [Abstract]

Schedule of Maturities of Long-term Debt

The maturity profile is as follows:



Fiscal year (in thousands)	Term Loan
2016	$	21,342
2017	42,683
2018	45,054
2019	151,763
2020	168,564
	$	429,406

RESTRUCTURING (Tables)

3 Months Ended

Jun. 27, 2015

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve by Type of Cost

The following summarizes the restructuring costs for the three months ended June 27, 2015 and June 28, 2014:



	Three Months Ended June 27, 2015
(In thousands)	Restructuring Accrual Balance at March 28, 2015		Restructuring Costs Incurred		Less Payments			Less Non-Cash Adjustments			Restructuring Accrual Balance at June 27, 2015
Severance and other employee costs	$	16,393	$	6,859	$	(8,155	)	$	—		$	15,097
Other costs	219		2,175		(2,266		)	—			128
Accelerated depreciation	—		421		—			(421		)	—
Asset write-down	—		4		—			(4		)	—
Total	$	16,612	$	9,459	$	(10,421	)	$	(425	)	$	15,225



	Three Months Ended June 28, 2014
(in thousands)	Restructuring Accrual Balance at March 29, 2014		Restructuring Costs Incurred		Less Payments			Less Non-Cash Adjustments			Restructuring Accrual Balance at June 28, 2014
Severance and other employee costs	$	22,908	$	9,542	$	(7,133	)	$	—		$	25,317
Other costs	728		5,167		(5,493		)	—			402
Accelerated depreciation	—		260		—			(260		)	—
Asset write-down	—		96		—			(96		)	—
	$	23,636	$	15,065	$	(12,626	)	$	(356	)	$	25,719

Schedule of Restructuring and Related Costs



Transformation costs	Three Months Ended
(in thousands)	June 27, 2015		June 28, 2014
Transformation and other costs	$	5,326	$	7,678
Accelerated depreciation	31		250
Total	$	5,357	$	7,928



Restructuring costs	Three Months Ended
(in thousands)	June 27, 2015		June 28, 2014
Severance and other employee costs	$	6,859	$	9,542
Other costs	2,175		5,167
Accelerated depreciation	421		260
Asset disposal	4		96
Total	$	9,459	$	15,065

Total restructuring and transformation	$	14,816	$	22,993

COMPREHENSIVE INCOME (Tables)

3 Months Ended

Jun. 27, 2015

Stockholders' Equity Note [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following is a roll-forward of the components of Accumulated Other Comprehensive Income, net of tax, for the three months ended June 27, 2015:



(In thousands)	Foreign Currency			Defined Benefit Plans			Net Unrealized (Gain)/Loss on Derivatives			Total

Balance as of March 28, 2015	$	(20,512	)	$	(8,923	)	$	7,711		$	(21,724	)
Other comprehensive income (loss)/income before reclassifications	441			2			1,190			1,633
Amounts reclassified from Accumulated Other Comprehensive Income	—			—			(3,993		)	(3,993		)
Net current period other comprehensive (loss)/income	441			2			(2,803		)	(2,360		)
Balance as of June 27, 2015	$	(20,071	)	$	(8,921	)	$	4,908		$	(24,084	)

Reclassification out of Accumulated Other Comprehensive Income

Details pertaining to the amount reclassified from Accumulated Other Comprehensive Income for the three months ended June 27, 2015 are as follows:



	Amounts Reclassified from Other Comprehensive Income			Affected Line in the Statement of Income
Derivative instruments reclassified to income statement
Realized net gain on derivatives	$	4,152		Revenue, cost of goods sold, income/(expense)
Income tax effect	(159		)	Provision for income taxes
Net of taxes	$	3,993

BASIS OF PRESENTATION (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Jun. 27, 2015	Mar. 28, 2015
Basis of Presentation [Line Items]
Correction of understatement, provision for income taxes	$ 1.0
Term of fiscal years	371 days	364 days
Term of quarters		91 days
First Three Quarters [Member]
Basis of Presentation [Line Items]
Term of quarters	91 days
Fourth Quarter [Member]
Basis of Presentation [Line Items]
Term of quarters	98 days

EARNINGS PER SHARE ("EPS") (Schedule of Earnings Per Share Reconciliation) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Basic EPS
Net loss	$ (267)	$ (3,649)
Basic weighted average shares (in shares)	51,360	51,741
Basic income (loss) per share (in dollars per share)	$ (0.01)	$ (0.07)
Diluted EPS
Net loss	$ (267)	$ (3,649)
Basic weighted average shares (in shares)	51,360	51,741
Net effect of common stock equivalents (in shares)	0	0
Diluted weighted average shares (in shares)	51,360	51,741
Diluted income (loss) per share (in dollars per share)	$ (0.01)	$ (0.07)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

STOCK-BASED COMPENSATION (Details) - USD ($)	3 Months Ended
STOCK-BASED COMPENSATION (Details) - USD ($)	Jun. 27, 2015	Jun. 28, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-based compensation expense recognized	$ 3,164,000	$ 3,489,000
Tax benefit from compensation expense	$ 0	$ 1,100,000
Weighted average fair value of options granted (in dollars per share)	$ 9.98	$ 7.49
Stock Options Black-Scholes assumptions (weighted average):
Volatility	22.38%	22.62%
Expected life (years)	4 years 10 months 24 days	4 years 10 months 24 days
Risk-free interest rate	1.75%	1.64%
Dividend yield	0.00%	0.00%
Total unrecognized compensation cost	$ 21,900,000
Total unrecognized compensation cost related to non-vested stock options, weighted average period of recognition	2 years 1 month 17 days
Shares purchased under the ESPP (in shares)	73,360	96,853
Shares purchased under the ESPP (in dollars per share)	$ 30.84	$ 25.85

PRODUCT WARRANTIES (Schedule of Product Warranty Liability) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Product Warranties [Roll Forward]
Warranty accrual as of the beginning of the period	$ 531	$ 590
Warranty provision	172	75
Warranty spending	(266)	(154)
Warranty accrual as of the end of the period	$ 437	$ 511

INVENTORIES (Schedule of Inventories) (Details) - USD ($) $ in Thousands	Jun. 27, 2015	Mar. 28, 2015
Inventory Disclosure [Abstract]
Raw materials	$ 69,586	$ 71,794
Work-in-process	10,702	12,462
Finished goods	130,843	126,821
Inventories, net	$ 211,131	$ 211,077

DERIVATIVES AND FAIR VALUE MEASUREMENTS (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Designated as Hedging Instrument \| Cash Flow Hedging \| Foreign Exchange Contract
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCI (Effective Portion)	$ 1,183	$ (100)
Designated as Hedging Instrument \| Cash Flow Hedging \| Foreign Exchange Contract \| Net revenues, COGS, and SG&A
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion)	3,993	800
Designated as Hedging Instrument \| Cash Flow Hedging \| Foreign Exchange Contract \| Interest and other expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Amount Excluded from Effectiveness Testing	16
Designated as Hedging Instrument \| Interest Rate Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCI (Effective Portion)	7	$ 600
Amount Excluded from Effectiveness Testing	0
Designated as Hedging Instrument \| Interest Rate Swap [Member] \| Interest and other expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion)	0
Not Designated as Hedging Instrument \| Foreign Exchange Contract
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCI (Effective Portion)	0
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion)	0
Not Designated as Hedging Instrument \| Foreign Exchange Contract \| Interest and other expense, net
Derivative Instruments, Gain (Loss) [Line Items]
Amount Excluded from Effectiveness Testing	$ 621

DERIVATIVES AND FAIR VALUE MEASUREMENTS (Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets) (Details) - USD ($) $ in Thousands	Jun. 27, 2015	Mar. 28, 2015
Derivative Assets:
Derivative Assets	$ 5,647	$ 9,740
Derivative Liabilities:
Derivative Liabilities	1,482	2,658
Designated as Hedging Instrument \| Foreign Exchange Contract \| Other Current Assets
Derivative Assets:
Derivative Assets	5,647	9,740
Designated as Hedging Instrument \| Foreign Exchange Contract \| Other Current Liabilities
Derivative Liabilities:
Derivative Liabilities	1,334	2,499
Designated as Hedging Instrument \| Interest Rate Swap [Member] \| Other Current Liabilities
Derivative Liabilities:
Derivative Liabilities	$ 148	$ 159

DERIVATIVES AND FAIR VALUE MEASUREMENTS (Schedule of Financial Assets and Financial Liabilities Measured at Fair Value) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Change in fair value of contingent consideration	$ 83	$ 224
Fair Value, Measurements, Recurring [Member]
Assets
Money market funds	71,099
Designated foreign currency hedge contracts	5,647
Assets, Fair Value Disclosure, Total	76,746
Liabilities
Designated foreign currency hedge contracts	1,334
Designated interest rate swap	148
Contingent consideration	4,810
Liabilities, Fair Value Disclosure	6,292
Fair Value, Measurements, Recurring [Member] \| Quoted Market Prices for Identical Assets (Level 1)
Assets
Money market funds	71,099
Designated foreign currency hedge contracts	0
Assets, Fair Value Disclosure, Total	71,099
Liabilities
Designated foreign currency hedge contracts	0
Designated interest rate swap	0
Contingent consideration	0
Liabilities, Fair Value Disclosure	0
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2)
Assets
Money market funds	0
Designated foreign currency hedge contracts	5,647
Assets, Fair Value Disclosure, Total	5,647
Liabilities
Designated foreign currency hedge contracts	1,334
Designated interest rate swap	148
Contingent consideration	0
Liabilities, Fair Value Disclosure	1,482
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Assets
Money market funds	0
Designated foreign currency hedge contracts	0
Assets, Fair Value Disclosure, Total	0
Liabilities
Designated foreign currency hedge contracts	0
Designated interest rate swap	0
Contingent consideration	4,810
Liabilities, Fair Value Disclosure	4,810
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Contingent consideration as of March 28, 2015	$ 4,727

DERIVATIVES AND FAIR VALUE MEASUREMENTS (Narrative) (Details) $ in Thousands		3 Months Ended		12 Months Ended
	Dec. 21, 2012 USD ($) swap	Jun. 27, 2015 USD ($)	Jun. 28, 2014 USD ($)	Mar. 28, 2015 USD ($)	Aug. 01, 2012
Derivative [Line Items]
Percentage of sales generated outside the US		43.40%
Maturity period for foreign currency contracts (in years)		1 year
Designated foreign currency hedge contracts outstanding		$ 132,100		$ 145,800
Gains reclassified to AOCI in next 12 months		1,200
Non-designated foreign currency hedge contracts outstanding		38,000		$ 45,800
Term Loan [Member]
Derivative [Line Items]
Face amount of debt		475,000
Foreign Exchange Contract
Derivative [Line Items]
Maturity period for foreign currency contracts (in years)				1 year
Designated as Hedging Instrument \| Foreign Exchange Contract
Derivative [Line Items]
Deferred income tax expense (benefit)		(700)
Designated as Hedging Instrument \| Interest Rate Swap [Member]
Derivative [Line Items]
Deferred income tax expense (benefit)		100
Designated as Hedging Instrument \| Cash Flow Hedging \| Foreign Exchange Contract
Derivative [Line Items]
Amount of Gain (Loss) Recognized in AOCI (Effective Portion)		1,183	$ (100)
Designated as Hedging Instrument \| Interest Rate Swap [Member]
Derivative [Line Items]
Amount of Gain (Loss) Recognized in AOCI (Effective Portion)		7	600
Number of Interest Rate Derivatives Held \| swap	2
Description of variable rate basis	LIBOR
Derivative, fixed interest rate	0.68%
Notional amount of derivative	$ 250,000
Net revenues, COGS, and SG&A \| Designated as Hedging Instrument \| Cash Flow Hedging \| Foreign Exchange Contract
Derivative [Line Items]
Amount of Gain/(Loss) Reclassified from AOCI into Earnings (Effective Portion)		$ 3,993	$ 800
Pall Corporation [Member] \| Term Loan [Member]
Derivative [Line Items]
Adjusted Libor Rounding Percentage					6.25%

INCOME TAXES (Details) - USD ($) $ in Millions	3 Months Ended
INCOME TAXES (Details) - USD ($) $ in Millions	Jun. 27, 2015	Jun. 28, 2014
Income Tax Contingency [Line Items]
Reported tax rate	116.70%	13.30%
Recorded tax expense due to tax rate increase in Puerto Rico	$ 1.0
Minimum [Member] \| Puerto Rico
Income Tax Contingency [Line Items]
Reported tax rate	15.00%
Maximum [Member] \| Puerto Rico
Income Tax Contingency [Line Items]
Reported tax rate	20.00%

DEBT (Details) $ in Thousands	3 Months Ended
DEBT (Details) $ in Thousands	Jun. 27, 2015 USD ($)
Debt Instrument [Line Items]
Debt outstanding	$ 429,406
2015	21,342
2016	42,683
2017	45,054
2018	151,763
2019 and beyond	$ 168,564
Credit Agreement [Member]
Debt Instrument [Line Items]
Term of credit facilities	5 years
Debt outstanding	$ 429,400
Credit Agreement [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Effective interest rate	1.5625%
Credit Agreement [Member] \| London Interbank Offered Rate (LIBOR) [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Interest Rate	1.125%
Credit Agreement [Member] \| London Interbank Offered Rate (LIBOR) [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Interest Rate	1.50%
Term Loan [Member]
Debt Instrument [Line Items]
Face amount of debt	$ 475,000
Debt outstanding	379,400
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Face amount of debt	50,000
Debt outstanding	50,000
Maximum borrowing capacity	$ 100,000

COMMITMENTS AND CONTINGENCIES (Details)	Jun. 27, 2015 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Damages claimed	$ 3,700,000
Amount accrued	$ 0

SEGMENT INFORMATION (Details)	3 Months Ended
SEGMENT INFORMATION (Details)	Jun. 27, 2015 segment
Segment Reporting [Abstract]
Number of reportable segments	1

RESTRUCTURING (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Restructuring Cost and Reserve [Line Items]
Expected cost	$ 45,000
Restructuring Costs Incurred	9,459	$ 15,065
Transformation costs	$ 5,357	$ 7,928

RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Restructuring Reserve [Roll Forward]
Restructuring Accrual Balance	$ 16,612	$ 23,636
Restructuring Costs Incurred	9,459	15,065
Less Payments	(10,421)	(12,626)
Less Non-Cash Adjustments	425	356
Restructuring Accrual Balance	15,225	25,719
Severance and other employee costs
Restructuring Reserve [Roll Forward]
Restructuring Accrual Balance	16,393	22,908
Restructuring Costs Incurred	6,859	9,542
Less Payments	(8,155)	(7,133)
Less Non-Cash Adjustments	0	0
Restructuring Accrual Balance	15,097	25,317
Other costs
Restructuring Reserve [Roll Forward]
Restructuring Accrual Balance	219	728
Restructuring Costs Incurred	2,175	5,167
Less Payments	(2,266)	(5,493)
Less Non-Cash Adjustments	0	0
Restructuring Accrual Balance	128	402
Accelerated depreciation
Restructuring Reserve [Roll Forward]
Restructuring Accrual Balance	0	0
Restructuring Costs Incurred	421	260
Less Payments	0	0
Less Non-Cash Adjustments	(421)	(260)
Restructuring Accrual Balance	0	0
Asset write-down
Restructuring Reserve [Roll Forward]
Restructuring Accrual Balance	0	0
Restructuring Costs Incurred	4	96
Less Payments	0	0
Less Non-Cash Adjustments	(4)	(96)
Restructuring Accrual Balance	$ 0	$ 0

RESTRUCTURING (Schedule of Restructuring and Related Costs) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Restructuring Cost and Reserve [Line Items]
Transformation costs	$ 5,357	$ 7,928
Restructuring Costs Incurred	9,459	15,065
Total restructuring and transformation	14,816	22,993
Severance and other employee costs
Restructuring Cost and Reserve [Line Items]
Restructuring Costs Incurred	6,859	9,542
Other costs
Restructuring Cost and Reserve [Line Items]
Restructuring Costs Incurred	2,175	5,167
Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring Costs Incurred	421	260
Asset disposal
Restructuring Cost and Reserve [Line Items]
Restructuring Costs Incurred	4	96
Transformation and other costs
Restructuring Cost and Reserve [Line Items]
Transformation costs	5,326	7,678
Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Transformation costs	$ 31	$ 250

CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014	Mar. 28, 2015
Research and Development [Abstract]
Capitalized software development costs for ongoing initiatives	$ 3.9	$ 1.4
Software costs capitalized, net	43.6		$ 39.7
Total costs capitalized related to in process software development initiatives	5.9		$ 7.9
Capitalized software development costs placed into service	$ 5.8

ACCUMULATED OTHER COMPREHENSIVE INCOME (Details 1) $ in Thousands	3 Months Ended
	Jun. 27, 2015 USD ($)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance as of March 28, 2015	$ (21,724)
Other comprehensive income (loss)/income before reclassifications	1,633
Amounts reclassified from Accumulated Other Comprehensive Income	(3,993)
Net current period other comprehensive (loss)/income	(2,360)
Balance as of June 27, 2015	(24,084)
Foreign Currency
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance as of March 28, 2015	(20,512)
Other comprehensive income (loss)/income before reclassifications	441
Amounts reclassified from Accumulated Other Comprehensive Income	0
Net current period other comprehensive (loss)/income	441
Balance as of June 27, 2015	(20,071)
Defined Benefit Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance as of March 28, 2015	(8,923)
Other comprehensive income (loss)/income before reclassifications	2
Amounts reclassified from Accumulated Other Comprehensive Income	0
Net current period other comprehensive (loss)/income	2
Balance as of June 27, 2015	(8,921)
Net Unrealized (Gain)/Loss on Derivatives
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance as of March 28, 2015	7,711
Other comprehensive income (loss)/income before reclassifications	1,190
Amounts reclassified from Accumulated Other Comprehensive Income	(3,993)
Net current period other comprehensive (loss)/income	(2,803)
Balance as of June 27, 2015	$ 4,908

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

ACCUMULATED OTHER COMPREHENSIVE INCOME (Details 2) - USD ($) $ in Thousands	3 Months Ended
	Jun. 27, 2015	Jun. 28, 2014
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Realized net gain on derivatives	$ (2,009)	$ (2,543)
Income tax effect	(1,864)	560
Net of taxes	(267)	$ (3,649)
Net Unrealized (Gain)/Loss on Derivatives \| Amounts Reclassified from Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Realized net gain on derivatives	4,152
Income tax effect	(159)
Net of taxes	$ 3,993

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details